Research Projects & Grants

• Prevalance of type 2 diabetes among minority groups, Role: PI, (12/2004 - 12/2005) Status: Completed

College/University

• All of Us Southern California Consortium, Role: Co-Investigator, University of California, Irvine, (05/2024 - 03/2025) Status: Closed

For Profit Organization

• Effectiveness of semaglutide 2.4 mg vs. commercially available medications for chronic weight management in participants with obesity in a multi-employer setting in the US – a pragmatic clinical study (POSEY), Role: Investigator, Novo Nordisk Pharmaceuticals Inc., (10/2022) Status: Approved
• A comparison of ThermaCare heat wraps to Icy hot cream and Icy hot patches for deep tissue heat penetration: A pilot study, Role: Investigator, Wyeth Pharmaceuticals, Inc., (04/2009 - 04/2010) Status: Completed
• All to target trial lantus® (insulin glargine) with stepwise addition of APIDRA® (insulin glulisine) or Lantus with one injection of Apidra vs. a twice-daily premixed insulin regimen (Novolog® mix 70/30™) in adult subjects with type 2 diabetes failing dual or triple therapy with oral agents: a 64-week, multi-center, randomized, parallel, open-label clinical study. Protocol No. HMR 1964A/3515, Role: PI, Sanofi-Synthelabo Pharmaceuticals, (05/2008 - 05/2009) Status: Completed
• The effect of various heating on skin blood flow, skin temperature and muscle temperature in man, Role: Investigator, Procter & Gamble Company, (01/2008 - 01/2009) Status: Completed
• An evaluation of six-day subcutaneous glucose sensor performance in subjects with type 1 diabetes mellitus, Role: PI, Medtronic, Inc., (10/2007 - 10/2008) Status: Completed
• A multicenter, randomized, double-blind, active controlled study to compare the effect of 24 weeks treatment with vildagliptin 100 mg qd or metformin 1500 mg daily in elderly drug naïve patients with type 2 diabetes LAF237/vildagliptin Protocol number CLAF237A2398, Role: PI, Novartis Pharmaceuticals Corporation, (08/2007 - 08/2008) Status: Completed
• Outpatient intensive cardiovascular disease secondary prevention and diabetes management program, Role: PI, GlaxoSmithKline, (02/2007 - 01/2008) Status: Completed
• The effect of the local application of hot packs on skin blood flow and skin temperature in control subjects and people with type 2 diabetes, Role: Investigator, Procter & Gamble Company, (03/2006 - 03/2007) Status: Completed
• Pilot study to identify effective methods of training pump naive subjects to use the paradigm® 722 system and to describe clinical effectiveness compared to subjects continuing with multiple dose injections (MDI) of insulin (STAR2), Role: PI, Medtronic, Inc., (10/2005 - 10/2006) Status: Completed
• Feasibility Study with Personalized Closed Loop (PCL), Role: Investigator, Medtronic, Inc., Status: Completed
• Use of the Guardian™ Connect system with Smart Connected Devices: CIP 331, Role: Investigator, Medtronic, Inc., Status: Completed
• ABC [Afrezza with Basal Combination]: A Phase 4 Study of Mealtime Control with Afrezza in Adult Subjects with Type I Diabetes Mellitus in Combination with an Automated Insulin Pump or Insulin Degludec, Role: Investigator, MannKind Corporation, Status: Completed
• INHALE-3: A 17-Week Randomized Trial and a 13-Week Extension, Evaluating the Efficacy and Safety of Inhaled Insulin (Afrezza® ) Combined with Insulin Degludec Versus Usual Care in Adults with Type 1 Diabetes, Role: Investigator, MannKind Corporation, Status: Completed
• IMPACT2: In-Home Study with MiniMed™ 780G Pump Automated Control in Type 2 - Evaluation of the AHCL System Insulin-requiring Type 2 Diabetes, Role: PI, Medtronic, Inc., (04/2025) Status: Completed

Internal

• Balance and diabetes, Role: Investigator, LLU Dept. of Physical Therapy, (03/2009 - 03/2010) Status: Completed
• Interactions between skin temperature, skin moisture and skin blood flow, Role: Investigator, LLU Dept. of Physical Therapy, (10/2008 - 10/2009) Status: Completed
• Interaction between vibration and skin temperature and altering skinblood flow in younger people, older people, and people with diabetes, Role: Investigator, LLU Dept. of Physical Therapy, (10/2008 - 10/2009) Status: Completed
• Interrelationship between color, light intesity and gait and balance with ageing and in people with and without Type 2 diabetes, Role: Investigator, LLU Dept. of Physical Therapy, (04/2008 - 04/2009) Status: Completed
• Endothelial function and heart rate variability during exercise in diabetic subjects, Role: Investigator, LLU Dept. of Physical Therapy, (11/2007 - 11/2008) Status: Completed
• Heat dissipation from the skin: interaction of global and local heat, skin moisture and blood flow, Role: Investigator, LLU Dept. of Physical Therapy, (09/2007 - 09/2008) Status: Completed
• Correlation between central and local control of endothelial function - the effect of ageing and diabetes, Role: Investigator, LLU Dept. of Physical Therapy, (03/2007 - 03/2008) Status: Completed
• Possible mechanisms for increased skin blood flow due to whole body vibration, Role: Investigator, LLU Dept. of Physical Therapy, (02/2007 - 02/2008) Status: Completed
• Evaluation of heat dissipation from heat wraps with and without foam insulation under various conditions, Role: Investigator, LLU Dept. of Physical Therapy, (12/2006 - 12/2007) Status: Completed
• The effect of 30 hz vs. 50 hz vibration on skin blood flow, Role: Investigator, LLU Dept. of Physical Therapy, (11/2006 - 11/2007) Status: Completed
• (INT) Residual-Diabetes, Role: PD/PI, LLU Dept. of Medicine, (08/2006 - 12/2026) Status: Awarded
• The effects of contrast baths on blood flow to the skin in normal and diabetic patients, Role: Investigator, LLU Dept. of Physical Therapy, (02/2006 - 02/2007) Status: Completed
• Diabetes management and medications, Role: Investigator, LLU Dept. of Physical Therapy, (10/2005 - 10/2006) Status: Completed
• Core strengthening in a geriatric population, Role: Investigator, LLU Dept. of Physical Therapy, (02/2005 - 02/2006) Status: Completed
• Criterion validity: comparison of two computerized posturography systems in a Type II Diabetes Mellitus population, Role: PI, LLU Dept. of Physical Therapy, (11/2004 - 11/2005) Status: Completed
• Balance, gait and diabetes, Role: Investigator, LLU Dept. of Physical Therapy, (10/2004 - 10/2005) Status: Completed
• Improvement in balance and gait parameters with Rosiglitazone in individuals with Type II Diabetes Mellitus, Role: Investigator, LLU Dept. of Physical Therapy, (09/2004 - 09/2005) Status: Completed
• Observational analysis of insulin pump therapy; diabetes outcomes and reimbursement, Role: PI, LLU Dept. of Medicine, (11/2003 - 11/2004) Status: Completed
• A quality improvement project to compare the efficacy of multiple daily injections to continous subcutaneous insulin infusion in controlling blood glucose levels in type 1 Diabetes and to further compare glucose control between a community CS II program to a tertiary center CS II program, Role: PI, LLU Dept. of Medicine, (10/2003 - 10/2004) Status: Completed
• A cross sectional analysis of different basal rate requirements for individuals on continuous subcutaneous insulin infusion., Role: PI, LLU Dept. of Medicine, (12/2002 - 12/2003) Status: Completed
• Outpatient intensive cardiovascular disease secondary prevention: DM cohort analysis, LLU School of Medicine, (09/2002 - 09/2003) Status: Closed
• The efficacy of the dual wave bolus feature in continous subcutaneous insulin infusion for controlling postprandial blood glucose in type 1 diabetes, Role: PI, LLU School of Medicine, Status: Completed
• Balance in patients with diabetes, Role: Investigator, LLU School of Allied Health Professionals, Status: Completed
• Retrospective analysis of the effects of thiazolidinedione therapy on lipid profiles in individuals with diabetes, Role: PI, LLU Dept. of Medicine, Status: Completed
• Understanding the importance of financial contribution in relation to diabetes control; a quality improvement project, Role: PI, LLU Dept. of Medicine, Status: Completed